HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel mitochondrial alanyl-tRNA synthetase 2 (AARS2) heterozygous mutations in a Chinese patient with adult-onset leukoencephalopathy.

AbstractBACKGROUND:
Missense mutations in the mitochondrial alanyl-tRNA synthetase 2 (AARS2) gene are clinically associated with infantile mitochondrial cardiomyopathy or adult-onset leukoencephalopathy with early ovarian failure. To date, approximately 40 cases have been reported related to AARS2 mutations, while its genetic and phenotypic spectrum remains to be defined.
CASE PRESENTATION:
We identified a 24-year-old Chinese female patient with adult-onset leukoencephalopathy carrying novel compound heterozygous pathogenic mutations in the AARS2 gene (c.718C > T and c.1040 + 1G > A) using a whole-exome sequencing approach.
CONCLUSIONS:
Our findings further extend the mutational spectrum of AARS2-related leukoencephalopathy and highlight the importance of the whole-exome sequencing in precisely diagnosing adult-onset leukoencephalopathies.
AuthorsYan Fan, Jinming Han, Yanyan Yang, Tuanzhi Chen
JournalBMC neurology (BMC Neurol) Vol. 22 Issue 1 Pg. 214 (Jun 08 2022) ISSN: 1471-2377 [Electronic] England
PMID35676634 (Publication Type: Case Reports, Journal Article)
Copyright© 2022. The Author(s).
Chemical References
  • Alanine-tRNA Ligase
Topics
  • Adult
  • Alanine-tRNA Ligase (genetics)
  • China
  • Female
  • Humans
  • Leukoencephalopathies (genetics, pathology)
  • Magnetic Resonance Imaging
  • Mutation (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: